811
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of a new class of antimicrobial agents incorporating the indolin-2-one moiety

, , &
Pages 853-862 | Received 24 Mar 2012, Accepted 25 Apr 2012, Published online: 31 May 2012

References

  • Albrecht A, Koszuk JF, Modranka J, Rózalski M, Krajewska U, Janecka A et al. Synthesis and cytotoxic activity of gamma-aryl substituted alpha-alkylidene-gamma-lactones and alpha-alkylidene-gamma-lactams. Bioorg Med Chem 2008;16:4872–4882.
  • Moosavi-Movahedi AA, Hakimelahi S, Chamani J, Khodarahmi GA, Hassanzadeh F, Luo FT et al. Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity. Bioorg Med Chem 2003;11:4303–4313.
  • Levy LM, Cabrera GM, Wright JE, Seldes AM. 5H-furan-2-ones from fungal cultures of Aporpium caryae. Phytochemistry 2003;62:239–243.
  • Vale-Silva LA, Buchta V, Vokurková D, Pour M. Investigation of the mechanism of action of 3-(4-bromophenyl)-5-acyloxymethyl-2,5-dihydrofuran-2-one against Candida albicans by flow cytometry. Bioorg Med Chem Lett 2006;16:2492–2495.
  • Lattmann E, Dunn S, Niamsanit S, Sattayasai N. Synthesis and antibacterial activities of 5-hydroxy-4-amino-2(5H)-furanones. Bioorg Med Chem Lett 2005;15:919–921.
  • Khan MS, Husain A. Syntheses and reactions of some new 2-arylidene-4-(biphenyl-4-yl)-but-3-en-4-olides with a study of their biological activity. Pharmazie 2002;57:448–452.
  • Husain A, Khan MS, Hasan SM, Alam MM. 2-Arylidene-4-(4-phenoxy-phenyl)but-3-en-4-olides: synthesis, reactions and biological activity. Eur J Med Chem 2005;40:1394–1404.
  • Leite L, Jansone D, Veveris M, Cirule H, Popelis Y, Melikyan G. 2-Arylidene-4-(4-phenoxy-phenyl)but-3-en-4-olides: Synthesis, reactions and biological activity. Eur J Med Chem 1999;34:859–865.
  • Black WC, Brideau C, Chan CC, Charleson S, Cromlish W, Gordon R et al. 3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility. Bioorg Med Chem Lett 2003;13:1195–1198.
  • Zarghi A, Praveen Rao PN, Knaus EE. Synthesis and biological evaluation of methanesulfonamide analogues of rofecoxib: Replacement of methanesulfonyl by methanesulfonamido decreases cyclooxygenase-2 selectivity. Bioorg Med Chem 2007;15:1056–1061.
  • Hashem AI, Youssef AS, Kandeel KA, Abou-Elmagd WS. Conversion of some 2(3H)-furanones bearing a pyrazolyl group into other heterocyclic systems with a study of their antiviral activity. Eur J Med Chem 2007;42:934–939.
  • Harvey SC. (1985). Ramington’s pharmaceutical science. Easton, PA: Mack Publishing Company, 1189.
  • Shin SS, Byun Y, Lim KM, Choi JK, Lee KW, Moh JH et al. In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives. J Med Chem 2004;47:792–804.
  • Lau CK, Brideau C, Chan CC, Charleson S, Cromlish WA, Ethier D, Gauthier JY, Gordon R, Guay J, Kargman S, Li CS, Prasit P, Riendeau D, Therien M, Visco DM, Xu L. Synthesis and biological evaluation of 3-heteroarizoxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors. Bioоrg Med Chem Lett 1999;9:3187–3192.
  • Lattmann E, Kinchington D, Dunn S, Singh H, Ayuko WO, Tisdale MJ. Cytotoxicity of 3,4-dihalogenated 2(5H)-furanones. J Pharm Pharmacol 2004;56:1163–1170.
  • Heindel ND, Minatelli JA. Synthesis and antibacterial and anticancer evaluations of alpha-methylene-gamma-butyrolactones. J Pharm Sci 1981;70:84–86.
  • Mologni L, Rostagno R, Brussolo S, Knowles PP, Kjaer S, Murray-Rust J et al. Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors. Bioorg Med Chem 2010;18:1482–1496.
  • Beauchard A, Laborie H, Rouillard H, Lozach O, Ferandin Y, Le Guével R et al. Synthesis and kinase inhibitory activity of novel substituted indigoids. Bioorg Med Chem 2009;17:6257–6263.
  • Zhang W, Go ML. Functionalized 3-benzylidene-indolin-2-ones: inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity. Bioorg Med Chem 2009;17:2077–2090.
  • Wee XK, Yeo WK, Zhang B, Tan VB, Lim KM, Tay TE et al. Synthesis and evaluation of functionalized isoindigos as antiproliferative agents. Bioorg Med Chem 2009;17:7562–7571.
  • Andreani A, Bellini S, Burnelli S, Granaiola M, Leoni A, Locatelli A et al. Substituted E-3-(3-indolylmethylene)-1,3-dihydroindol-2-ones with antitumor activity. In depth study of the effect on growth of breast cancer cells. J Med Chem 2010;53:5567–5575.
  • Sun L, Liang C, Shirazian S, Zhou Y, Miller T, Cui J et al. Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. J Med Chem 2003;46:1116–1119.
  • Sun CL, Christensen JG, McMahon G. (2009). In: Li R, Stafford JA. eds. Kinase Inhibitor Drugs. Hoboken, New Jersey: John Wiley & Sons Inc., Chapter 1.
  • Mohamed MI. Synthesis and antibacterial activity of some novel heterocycles. J Bulg Chem Commun 2004;36:241–248.
  • Mohamed MI, Zaky HT, Kandile NG. Novel synthesis and antibacterial activity of some pyridazine derivatives. J Chinese Chem Soc 2004;51:963–968.
  • Mohamed MI, Zaky HT, Mohamed HM, Kandile NG. Novel heterocyclic systems of pyridazines. Afinidad 2005;62:48–56.
  • Mohamed MI. Synthesis and antimicrobial activity of new pyridazinyl sulfonamide derivatives. J Bulg Chem Commun 2007;39:152–158.
  • Kandile NG, Mohamed MI, Zaky HT, Mohamed HM. Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation. Eur J Med Chem 2009;44:1989–1996.
  • Kandile NG, Mohamed MI, Zaky HT, Mohamed HM. Silver nanoparticles effect on antimicrobial and antifungal activity of new heterocycles. Bull Korean. Chem Soc 2010;31:3530–3538.
  • El Abbady AM, Omara MA, Kandile NG. Condensation of β-Aroylpropionic Acids With Isatin Under Perkin Conditions. Rev Roum Chem 1974;19:79–82.
  • Hamad A-SS, Kandile NG, Zaky HT, Mohamed MI, Ahmed HM. Conversion of 2(3H)-furanones bearing indole nuclei into novel amide, pyrrolone, and imidazole derivatives. Heteroatom Chem 2003;14:434–442.
  • Hamad A-SS, Kandile NG, Zaky HT, Mohamed MI, Ahmed HM. 2(3H)-Furanones as synthons for polyamides of 1,3-diazines and 1,3,5-triazines. Arkivok 2006;10:162–172.
  • Zaky HT. New oxazolones as synthons for antimicrobial compounds. J Bulg Chem Commun 2007;39:134–141.
  • Zaky HT. 3,1- Benzothiazine,benzimidazol,amide and quinazoline derivatives via 2(3H) Furanones. J Bulg Chem Commun 2006;38:248–254.
  • Kandile NG, Zaky HT, Mohamed MI, Ismaeel HM, Ahmed NA.. Synthesis, characterization and in vitro antimicrobial evaluation of new compounds incorporating oxindole nucleus. J Enz Inhib Med Chem ,Early online 1-10 (2011).
  • Ahmad S, Rathish IG, Bano S, Alam MS, Javed K. Synthesis and biological evaluation of some novel 6-aryl-2-(p-sulfamylphenyl)-4,5-dihydropyridazin-3(2H)-ones as anti-cancer, antimicrobial,and anti-inflammatory agents. J Enzyme. Inhib Med Chem 2010;25:266–271.
  • Tadeg H, Mohammed E, Asres K, Gebre-Mariam T. Antimicrobial activities of some selected traditional Ethiopian medicinal plants used in the treatment of skin disorders. J Ethnopharmacol 2005;100:168–175.
  • Karthikeyan SM, Prasad JD, Mahalinga M, Holla SB, Kumari SB. Antimicrobial studies of 2,4-dichloro-5-fluorophenyl containing oxadiazoles. Eur J Med Chem 2008;43:25–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.